# Amgen revenue entity: /record/amgen.md predicate: revenue page: /record/amgen/revenue as_of: 2026-11-08 cite: AsOf. "Amgen quarterly revenue: 10,365,000,000 United States dollar", as of 2026-09-30. Claim clm_985DF46177C9, https://asof.is/claim/clm_985DF46177C9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm. As of November 8, 2026, the latest revenue figure on the AsOf record for Amgen is $10.37 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). Amgen's latest full-year revenue is $36.75 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 19 claims on Amgen's revenue, 1 open and 18 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest revenue The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_revenue claim, kept apart from the full-year series. Every quarterly revenue figure: /record/amgen/quarterly_revenue.md - [Amgen](/record/amgen.md) | quarterly_revenue | 10,365,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_985DF46177C9](/claim/clm_985DF46177C9.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm ## Latest full-year revenue What the record asserts on 2026-11-08. - [Amgen](/record/amgen.md) | revenue | 36,751,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_3DD4895A6205](/claim/clm_3DD4895A6205.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/0000318154-26-000010-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Amgen](/record/amgen.md) | revenue | 14,771,000,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_52AE9BB2B908](/claim/clm_52AE9BB2B908.md) | [clm_51956A4A09F8](/claim/clm_51956A4A09F8.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000119312510044311/0001193125-10-044311-index.htm - [Amgen](/record/amgen.md) | revenue | 15,003,000,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_B7B415A6CD44](/claim/clm_B7B415A6CD44.md) | [clm_52AE9BB2B908](/claim/clm_52AE9BB2B908.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000119312510044311/0001193125-10-044311-index.htm - [Amgen](/record/amgen.md) | revenue | 14,642,000,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_21002187AEE3](/claim/clm_21002187AEE3.md) | [clm_B7B415A6CD44](/claim/clm_B7B415A6CD44.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000119312510044311/0001193125-10-044311-index.htm - [Amgen](/record/amgen.md) | revenue | 15,053,000,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_C7A9E438A984](/claim/clm_C7A9E438A984.md) | [clm_21002187AEE3](/claim/clm_21002187AEE3.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000095012311018800/0000950123-11-018800-index.htm - [Amgen](/record/amgen.md) | revenue | 15,582,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_EC47C2B5A921](/claim/clm_EC47C2B5A921.md) | [clm_C7A9E438A984](/claim/clm_C7A9E438A984.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000119312512086670/0001193125-12-086670-index.htm - [Amgen](/record/amgen.md) | revenue | 17,265,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_3D7A43128430](/claim/clm_3D7A43128430.md) | [clm_EC47C2B5A921](/claim/clm_EC47C2B5A921.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000144530513000364/0001445305-13-000364-index.htm - [Amgen](/record/amgen.md) | revenue | 18,676,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_4F9F8554DED3](/claim/clm_4F9F8554DED3.md) | [clm_3D7A43128430](/claim/clm_3D7A43128430.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815414000004/0000318154-14-000004-index.htm - [Amgen](/record/amgen.md) | revenue | 20,063,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_6460A66923A8](/claim/clm_6460A66923A8.md) | [clm_4F9F8554DED3](/claim/clm_4F9F8554DED3.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815415000005/0000318154-15-000005-index.htm - [Amgen](/record/amgen.md) | revenue | 21,662,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_33F31087C483](/claim/clm_33F31087C483.md) | [clm_6460A66923A8](/claim/clm_6460A66923A8.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815416000031/0000318154-16-000031-index.htm - [Amgen](/record/amgen.md) | revenue | 22,991,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_D4EEBB71EC7D](/claim/clm_D4EEBB71EC7D.md) | [clm_33F31087C483](/claim/clm_33F31087C483.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815417000004/0000318154-17-000004-index.htm - [Amgen](/record/amgen.md) | revenue | 22,849,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_340FB654E4B9](/claim/clm_340FB654E4B9.md) | [clm_D4EEBB71EC7D](/claim/clm_D4EEBB71EC7D.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815418000004/0000318154-18-000004-index.htm - [Amgen](/record/amgen.md) | revenue | 23,747,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_8EF1DBCB836F](/claim/clm_8EF1DBCB836F.md) | [clm_340FB654E4B9](/claim/clm_340FB654E4B9.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815419000008/0000318154-19-000008-index.htm - [Amgen](/record/amgen.md) | revenue | 23,362,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_2B6D201D77C0](/claim/clm_2B6D201D77C0.md) | [clm_8EF1DBCB836F](/claim/clm_8EF1DBCB836F.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815420000017/0000318154-20-000017-index.htm - [Amgen](/record/amgen.md) | revenue | 25,424,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_77883252E88F](/claim/clm_77883252E88F.md) | [clm_2B6D201D77C0](/claim/clm_2B6D201D77C0.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815421000010/0000318154-21-000010-index.htm - [Amgen](/record/amgen.md) | revenue | 25,979,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_142A6C7A0E55](/claim/clm_142A6C7A0E55.md) | [clm_77883252E88F](/claim/clm_77883252E88F.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815422000010/0000318154-22-000010-index.htm - [Amgen](/record/amgen.md) | revenue | 26,323,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_C49E0455CA9B](/claim/clm_C49E0455CA9B.md) | [clm_142A6C7A0E55](/claim/clm_142A6C7A0E55.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815423000017/0000318154-23-000017-index.htm - [Amgen](/record/amgen.md) | revenue | 28,190,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_F31DA2CA4F3F](/claim/clm_F31DA2CA4F3F.md) | [clm_C49E0455CA9B](/claim/clm_C49E0455CA9B.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/0000318154-24-000011-index.htm - [Amgen](/record/amgen.md) | revenue | 33,424,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_3DD4895A6205](/claim/clm_3DD4895A6205.md) | [clm_F31DA2CA4F3F](/claim/clm_F31DA2CA4F3F.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000010/0000318154-25-000010-index.htm - [Amgen](/record/amgen.md) | revenue | 36,751,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_3DD4895A6205](/claim/clm_3DD4895A6205.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/0000318154-26-000010-index.htm ## What replaced what - $14.77 billion (2007-12-31 to 2008-12-31, [clm_51956A4A09F8](/claim/clm_51956A4A09F8.md)) was replaced by $15 billion from 2008-12-31 ([clm_52AE9BB2B908](/claim/clm_52AE9BB2B908.md)) - $15 billion (2008-12-31 to 2009-12-31, [clm_52AE9BB2B908](/claim/clm_52AE9BB2B908.md)) was replaced by $14.64 billion from 2009-12-31 ([clm_B7B415A6CD44](/claim/clm_B7B415A6CD44.md)) - $14.64 billion (2009-12-31 to 2010-12-31, [clm_B7B415A6CD44](/claim/clm_B7B415A6CD44.md)) was replaced by $15.05 billion from 2010-12-31 ([clm_21002187AEE3](/claim/clm_21002187AEE3.md)) - $15.05 billion (2010-12-31 to 2011-12-31, [clm_21002187AEE3](/claim/clm_21002187AEE3.md)) was replaced by $15.58 billion from 2011-12-31 ([clm_C7A9E438A984](/claim/clm_C7A9E438A984.md)) - $15.58 billion (2011-12-31 to 2012-12-31, [clm_C7A9E438A984](/claim/clm_C7A9E438A984.md)) was replaced by $17.27 billion from 2012-12-31 ([clm_EC47C2B5A921](/claim/clm_EC47C2B5A921.md)) - $17.27 billion (2012-12-31 to 2013-12-31, [clm_EC47C2B5A921](/claim/clm_EC47C2B5A921.md)) was replaced by $18.68 billion from 2013-12-31 ([clm_3D7A43128430](/claim/clm_3D7A43128430.md)) - $18.68 billion (2013-12-31 to 2014-12-31, [clm_3D7A43128430](/claim/clm_3D7A43128430.md)) was replaced by $20.06 billion from 2014-12-31 ([clm_4F9F8554DED3](/claim/clm_4F9F8554DED3.md)) - $20.06 billion (2014-12-31 to 2015-12-31, [clm_4F9F8554DED3](/claim/clm_4F9F8554DED3.md)) was replaced by $21.66 billion from 2015-12-31 ([clm_6460A66923A8](/claim/clm_6460A66923A8.md)) - $21.66 billion (2015-12-31 to 2016-12-31, [clm_6460A66923A8](/claim/clm_6460A66923A8.md)) was replaced by $22.99 billion from 2016-12-31 ([clm_33F31087C483](/claim/clm_33F31087C483.md)) - $22.99 billion (2016-12-31 to 2017-12-31, [clm_33F31087C483](/claim/clm_33F31087C483.md)) was replaced by $22.85 billion from 2017-12-31 ([clm_D4EEBB71EC7D](/claim/clm_D4EEBB71EC7D.md)) - $22.85 billion (2017-12-31 to 2018-12-31, [clm_D4EEBB71EC7D](/claim/clm_D4EEBB71EC7D.md)) was replaced by $23.75 billion from 2018-12-31 ([clm_340FB654E4B9](/claim/clm_340FB654E4B9.md)) - $23.75 billion (2018-12-31 to 2019-12-31, [clm_340FB654E4B9](/claim/clm_340FB654E4B9.md)) was replaced by $23.36 billion from 2019-12-31 ([clm_8EF1DBCB836F](/claim/clm_8EF1DBCB836F.md)) - $23.36 billion (2019-12-31 to 2020-12-31, [clm_8EF1DBCB836F](/claim/clm_8EF1DBCB836F.md)) was replaced by $25.42 billion from 2020-12-31 ([clm_2B6D201D77C0](/claim/clm_2B6D201D77C0.md)) - $25.42 billion (2020-12-31 to 2021-12-31, [clm_2B6D201D77C0](/claim/clm_2B6D201D77C0.md)) was replaced by $25.98 billion from 2021-12-31 ([clm_77883252E88F](/claim/clm_77883252E88F.md)) - $25.98 billion (2021-12-31 to 2022-12-31, [clm_77883252E88F](/claim/clm_77883252E88F.md)) was replaced by $26.32 billion from 2022-12-31 ([clm_142A6C7A0E55](/claim/clm_142A6C7A0E55.md)) - $26.32 billion (2022-12-31 to 2023-12-31, [clm_142A6C7A0E55](/claim/clm_142A6C7A0E55.md)) was replaced by $28.19 billion from 2023-12-31 ([clm_C49E0455CA9B](/claim/clm_C49E0455CA9B.md)) - $28.19 billion (2023-12-31 to 2024-12-31, [clm_C49E0455CA9B](/claim/clm_C49E0455CA9B.md)) was replaced by $33.42 billion from 2024-12-31 ([clm_F31DA2CA4F3F](/claim/clm_F31DA2CA4F3F.md)) - $33.42 billion (2024-12-31 to 2025-12-31, [clm_F31DA2CA4F3F](/claim/clm_F31DA2CA4F3F.md)) was replaced by $36.75 billion from 2025-12-31 ([clm_3DD4895A6205](/claim/clm_3DD4895A6205.md)) ## Questions this record answers ### What is Amgen's current revenue? The latest figure on the record is $10.37 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $36.75 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 8, 2026. ### What was Amgen's revenue for the quarter ended September 30, 2026? $10.37 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did Amgen's revenue last change? The latest value on the record is $36.75 billion, dated December 31, 2025; before it the record holds $33.42 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was Amgen's revenue before $36.75 billion? $33.42 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/amgen/revenue (markdown: /record/amgen/revenue.md) - Entity twin: /record/amgen.md ยท timeline: /timelines/amgen.md - Every company's revenue: /facts/revenue.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.